These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Determining the origin of synchronous multifocal bladder cancer by exome sequencing. Acar Ö; Özkurt E; Demir G; Saraç H; Alkan C; Esen T; Somel M; Lack NA BMC Cancer; 2015 Nov; 15():871. PubMed ID: 26553077 [TBL] [Abstract][Full Text] [Related]
45. Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy. Teo MY; Guercio BJ; Arora A; Hao X; Regazzi AM; Donahue T; Herr HW; Goh AC; Cha EK; Pietzak E; Donat SM; Dalbagni G; Bochner BH; Olgac S; Sarungbam J; Sirintrapun SJ; Chen YB; Gopalan A; Fine SW; Tickoo SK; Reuter VE; Weigelt B; Schultheis AM; Funt SA; Bajorin DF; Solit DB; Iyer G; Ostrovnaya I; Rosenberg JE; Al-Ahmadie H Clin Genitourin Cancer; 2022 Oct; 20(5):431-441. PubMed ID: 35676169 [TBL] [Abstract][Full Text] [Related]
46. Genomic case report of a low grade bladder tumor metastasis to lung. Van Every MJ; Dancik G; Paramesh V; Gurda GT; Meier DR; Cash SE; Richmond CS; Guin S BMC Urol; 2018 Sep; 18(1):74. PubMed ID: 30176882 [TBL] [Abstract][Full Text] [Related]
47. Clinical review - small cell carcinoma of the bladder. Church DN; Bahl A Cancer Treat Rev; 2006 Dec; 32(8):588-93. PubMed ID: 17008012 [TBL] [Abstract][Full Text] [Related]
49. Primary pure small cell carcinoma of the urinary bladder that responded to carboplatin plus etoposide: a case report and review of the literature. Kaya AO; Coskun U; Yildiz R; Gonul II; Karagulle K; Yaman E; Ozturk B J BUON; 2009; 14(4):703-6. PubMed ID: 20148466 [TBL] [Abstract][Full Text] [Related]
50. Treatment Outcomes for Small Cell Carcinoma of the Bladder: Results From a UK Patient Retrospective Cohort Study. Chau C; Rimmer Frcr Y; Choudhury PhD A; Leaning Frcr D; Law A; Enting D; Lim Md JH; Hafeez PhD S; Khoo PhD V; Huddart PhD R; Mitchell Frcr D; Henderson Frcr DR; McGrane Frcr J; Beresford Frcr M; Vasudev PhD N; Beesley Frcr S; Hilman S; Manetta Frcr C; Sriram Frcs R; Sharma Md A; Eswar Frcr C; Treece Frcr S; Vilarino-Varela Frcr M; Varughese Frcr M; Glen PhD H; Pintus Md E; Crabb PhD S Int J Radiat Oncol Biol Phys; 2021 Jul; 110(4):1143-1150. PubMed ID: 33561506 [TBL] [Abstract][Full Text] [Related]
51. Genomic landscape of inverted urothelial papilloma and urothelial papilloma of the bladder. Isharwal S; Hu W; Sarungbam J; Chen YB; Gopalan A; Fine SW; Tickoo SK; Sirintrapun SJ; Jadallah S; Loo FL; Pietzak EJ; Cha EK; Bochner BH; Berger MF; Iyer G; Solit DB; Reuter VE; Al-Ahmadie H J Pathol; 2019 Jul; 248(3):260-265. PubMed ID: 30838648 [TBL] [Abstract][Full Text] [Related]
52. Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-Mutant Lung Cancers at risk for Histologic Transformation and Inferior Clinical Outcomes. Offin M; Chan JM; Tenet M; Rizvi HA; Shen R; Riely GJ; Rekhtman N; Daneshbod Y; Quintanal-Villalonga A; Penson A; Hellmann MD; Arcila ME; Ladanyi M; Pe'er D; Kris MG; Rudin CM; Yu HA J Thorac Oncol; 2019 Oct; 14(10):1784-1793. PubMed ID: 31228622 [TBL] [Abstract][Full Text] [Related]
53. Telomerase reverse transcriptase (TERT) promoter mutations in primary adenocarcinoma of bladder and urothelial carcinoma with glandular differentiation: pathogenesis and diagnostic implications. Cheng L; Lopez-Beltran A; Wang M; Montironi R; Kaimakliotis HZ; Zhang S Mod Pathol; 2021 Jul; 34(7):1384-1391. PubMed ID: 33674765 [TBL] [Abstract][Full Text] [Related]
54. TTF-1 Positive Primary Small Cell Carcinoma of the Breast: A Case Report and Review of the Literature. Boutrid H; Kassem M; Tozbikian G; Morgan E; White J; Shah M; Vandeusen J; Sardesai S; Williams N; Stover DG; Lustberg M; Wesolowski R; Pudavalli V; Williams TM; Konda B; Fortier S; Carbone D; Ramaswamy B; Cherian MA Front Endocrinol (Lausanne); 2020; 11():228. PubMed ID: 32411090 [TBL] [Abstract][Full Text] [Related]
55. Rhabdomyosarcoma of the urinary bladder in adults: predilection for alveolar morphology with anaplasia and significant morphologic overlap with small cell carcinoma. Paner GP; McKenney JK; Epstein JI; Amin MB Am J Surg Pathol; 2008 Jul; 32(7):1022-8. PubMed ID: 18469707 [TBL] [Abstract][Full Text] [Related]
56. Clonal origin of lymph node metastases in bladder carcinoma. Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038 [TBL] [Abstract][Full Text] [Related]
57. Molecular changes during progression from nonmuscle invasive to advanced urothelial carcinoma. Sjödahl G; Eriksson P; Patschan O; Marzouka NA; Jakobsson L; Bernardo C; Lövgren K; Chebil G; Zwarthoff E; Liedberg F; Höglund M Int J Cancer; 2020 May; 146(9):2636-2647. PubMed ID: 31609466 [TBL] [Abstract][Full Text] [Related]
58. SOX2 and Rb1 in esophageal small-cell carcinoma: their possible involvement in pathogenesis. Ishida H; Kasajima A; Kamei T; Miura T; Oka N; Yazdani S; Ozawa Y; Fujishima F; Sakurada A; Nakamura Y; Tanaka Y; Kurosumi M; Ishikawa Y; Okada Y; Ohuchi N; Sasano H Mod Pathol; 2017 May; 30(5):660-671. PubMed ID: 28106103 [TBL] [Abstract][Full Text] [Related]
59. Small Cell Carcinoma of the Urinary Bladder: A Retrospective, Multicenter Rare Cancer Network Study of 107 Patients. Pasquier D; Barney B; Sundar S; Poortmans P; Villa S; Nasrallah H; Boujelbene N; Ghadjar P; Lassen-Ramshad Y; Senkus E; Oar A; Roelandts M; Amichetti M; Vees H; Zilli T; Ozsahin M Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):904-10. PubMed ID: 26104942 [TBL] [Abstract][Full Text] [Related]
60. Mutational context and diverse clonal development in early and late bladder cancer. Nordentoft I; Lamy P; Birkenkamp-Demtröder K; Shumansky K; Vang S; Hornshøj H; Juul M; Villesen P; Hedegaard J; Roth A; Thorsen K; Høyer S; Borre M; Reinert T; Fristrup N; Dyrskjøt L; Shah S; Pedersen JS; Ørntoft TF Cell Rep; 2014 Jun; 7(5):1649-1663. PubMed ID: 24835989 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]